Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Abeona Therapeutics (ABEO).
Abeona Therapeutics Inc. has strengthened its Board of Directors with the appointment of Dr. Bernhardt G. Zeiher and Dr. Eric Crombez, both recognized as independent directors. With extensive backgrounds in pharmaceuticals and medical practice, Dr. Zeiher brings experience from his time at Astellas Pharma and other industry positions, while Dr. Crombez’s expertise stems from his roles at Ultragenyx and Dimension Therapeutics, as well as his academic tenure at UCLA. Both appointees have no familial ties to the company’s executives and have been offered annual compensation and stock awards as part of their board membership.
Find detailed analytics on ABEO stock on TipRanks’ Stock Analysis page.